Archived NHGRI record

2018 State Bills Washington 2018 HB 2565

Washington

Status: Died
Database: NHGRI archive
Source database updated: February 8, 2024
Snapshot retrieved: September 1, 2026

Summary

Substitute bill version: Requires the drug utilization review board to consider the safety, efficacy, and cost-effectiveness of drugs and gene therapies in its recommendations to the director of the authority regarding coverage for medical assistance programs. Died.

Record details

Archived source metadata

Jurisdiction: Washington
Status: Died
NHGRI topic(s): Health Insurance Coverage
Record year or session: 2018
NHGRI database updated: February 8, 2024
Snapshot retrieved: September 1, 2026 at 2:32 AM UTC
Source row: 468
Stable source ID: nhgri-c1fe7cc30983150117eb
Permanent URL: https://whoownsyourdna.org/source-records/nhgri/nhgri-c1fe7cc30983150117eb/

Source links

Archive details

Courtesy: National Human Genome Research Institute. This archive preserves the state, primary link, topic, bill status, and summary retrieved from NHGRI.

Report a source problem

Report a transcription problem, changed legal status, or newer official source for human review. Any correction remains separate from the archived NHGRI wording.

Submit information about this archived record

Cite this archived record

NHGRI Genome Statute and Legislation Database. 2018 State Bills Washington 2018 HB 2565. Archived by Who Owns Your DNA? Retrieved September 1, 2026. https://whoownsyourdna.org/source-records/nhgri/nhgri-c1fe7cc30983150117eb/